Worst performer was last week's Share of the Week RED:RedT Energy, which dropped 15% and gave up half of last week's gains. Just when I thought it may be creeping back towards profit, it's down by 24%.
Only one share had a climb of 5% or more this week, and so Share of the Week is JLP:Jubilee Metals. The climb was just 5% and this is still 45% down and in desperate need of some good news about something to recover my losses.
That's it - nothing else interesting - what a dull week!
At least the massive spike will have a little step in it now - and hopefully a valley.
Here's the ISA and share portfolios
| Weekly Change | |||
| Cash | £10.36 | -£0 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £66,840.50 | (17.3%) | -£154.28 |
| Potential profits | £16,959.49 | -£116.32 | |
| Yr 4 Dividends | £29.56 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £910.37 | (19.2%) | -£303.45 |
| Total Dividends | £1,267.89 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £558.37 | (11.8%) | -£3.51 |
| (Sold stocks profit + Dividends - Fees / Months) |
You can tell it's a week when the OPTI:Optibiotix share price remained unchanged. Tiny movements elsewhere meant not much happened.
The recent dip has been painful, but when I look at the last 6 months in the red, the current situation is amazing.
Here's the SIPP after week 144
| Weekly Change | |||
| Cash | £56.00 | +£0 | |
| Portfolio cost | £27,893.76 | +£0 | |
| Portfolio sell value (bid price - commission) | £33,961.50 | (21.8%) | -£236.66 |
| Potential profits | £9,173.74 | -£102.75 | |
| Yr 3 Dividends | £292.57 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £196.59 | (8.5%) | -£5.04 |
| Total Dividends | £1,208.67 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £346.31 | (14.9%) | -£2.42 |
| (Sold stocks profit + Dividends - Fees / Months) |
Everything except TRX:Tissue Regenix either dropped or stayed the same this week. The drop in paper profits was CAML:Central Asia Metals taking a 3% hit, and there were another £130 of deepening losses.
All still looking good. Most impressed that this has only been in the red on 5 occasions in the last 12 months. A very well behaved portfolio.
The trading account looks like this after week 110
| Weekly Change | |||
| Cash | £151.47 | -£499.46 | |
| Portfolio cost | £2,321.29 | +£499.46 | |
| Portfolio sell value (bid price - commission) | £1,932.03 | (-16.8%) | -£53.35 |
| Potential profits | £37.44 | +£3.36 | |
| Year 3 Dividends | £0 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £127.88 | (66.1%) | -£25.57 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£2.49 | (-1.3%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
When IQE:IQE interims came out and the share price was hammered, I was too slow to react and get a bargain. However, I bought 478 shares at 101.99p costing £499.46 as I decided there was no more scope for bad news and the shorters would start to close. I was wrong and the price dropped to 97.75p yesterday, so I'm already down 9% and decidedly miffed.
Nearly everything else dropped too, except TAP:Taptica which climbed by 1% and gave me the extra £3 potential profits - Woohoo! They are up by 8% now, but it's only £37 so I really need some good results in a few weeks time so I can make the £65 for this portfolio to have broken even.
At least since the injection of an extra £2,000 this account has become much, much more interesting.
Still a long way to go before the value overtakes the cash I've injected.
Thursday saw the long-awaited OPTI:Optibiotix interims. My excitement levels had been really building - surely we would see signs of revenue, and maybe they would take the chance to give news of some more deals, as it's been 2 months since the last one.
Nope!
Revenues were dreadful - a meagre £80K. I was expecting Go Figure to have beaten that on it's own. The problem is the cutoff period was May, and all the new exciting stuff has kicked off since May, so I guess my optimism was a little guided by fantasy rather than reality.
The share price was absolutely hammered, but fortunately recovered by the end of the week, so ending flat was a good thing. Slightly frustrating that I sold all my VRS:Versarien shares to pile into OPTI:Optibiotix because they are so much nearer to revenue, only for VRS:Versarien to zoom ahead past 150p. My plan to buy back in below 100p after a spike because that's what happened to OPTI:Optibiotix looks like a complete failure. Clearly graphene is more sexy to the market than gut bacteria!
I must keep reminding myself that I'm still making 50% paper profit on OPTI:Optibiotix. That's a hell of a lot more positive than the losses I've been sitting on for so long. I must stop worrying about daily movements and focus on the massive revenue streams about to hit over the next 12 months, and that big SBTX:SkinBioTherapeutics dividend that will be ample reward for the frustrations of being a long term holder while all around you trade.
No comments:
Post a Comment